Noroozi-aghideh A, Kheirandish M. Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review. World J Stem Cells 2019; 11(2): 73-83 [PMID: 30842806 DOI: 10.4252/wjsc.v11.i2.73]
Corresponding Author of This Article
Maryam Kheirandish, PhD, Associate Professor, Immunology Department, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine (IBTO), Hemmat high way next to Milad tower, Tehran 14665-1157, Iran. m.kheirandish@ibto.ir
Research Domain of This Article
Cell Biology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Stem Cells. Feb 26, 2019; 11(2): 73-83 Published online Feb 26, 2019. doi: 10.4252/wjsc.v11.i2.73
Human cord blood-derived viral pathogens as the potential threats to the hematopoietic stem cell transplantation safety: A mini review
Ali Noroozi-aghideh, Maryam Kheirandish
Ali Noroozi-aghideh, Department of Hematology, Faculty of Paramedicine, Aja University of Medical Sciences, Tehran 14665-1157, Iran
Maryam Kheirandish, Immunology Department, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine (IBTO), Tehran 14665-1157, Iran
Author contributions: The author contributed equally to this work.
Conflict-of-interest statement: Authors of this manuscript have no conflicts of interest to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Maryam Kheirandish, PhD, Associate Professor, Immunology Department, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine (IBTO), Hemmat high way next to Milad tower, Tehran 14665-1157, Iran. m.kheirandish@ibto.ir
Telephone: +98-21-88629538 Fax: +98-21-88601577
Received: December 12, 2018 Peer-review started: December 12, 2018 First decision: December 24, 2018 Revised: January 14, 2019 Accepted: January 26, 2019 Article in press: January 26, 2019 Published online: February 26, 2019 Processing time: 76 Days and 18.1 Hours
Core Tip
Core tip: Severe infectious complications, especially due to viral pathogens remain the leading cause of the post-transplantation morbidity and mortality. In this context, excluding the viral-contaminated umbilical cord blood (UCB) units might be an effective policy to reduce the infection rate after UCB transplantation (UCBT). Complete prevention of the transmission of donor-derived viral pathogens via UCB is not possible. However, having the knowledge of the transmission route and the prevalence of viruses will improve the transplantation safety by controlled patient management. This minireview summarizes the general aspects concerning the prevalence, characteristics and risk factors of viral infections with a focus on the impact on UCBT safety.
